CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SIREN project aims to develop a highly sensitive liquid biopsy test using surface-enhanced Raman scattering (SERS) to detect cancer biomarkers in blood plasma and urine. This technology seeks to improve early diagnosis of breast cancer by analyzing biomolecular profiles in a label-free manner, enhancing clinical de…
Despite current large-scale mammography screening programmes, breast cancer is still the leading cause of cancer death in women in the vast majority of countries.
It is recognizable that cancer deaths could be prevented through earlier diagnosis and adequate treatment.
Therefore, new vigilant diagnostic tools that could provide an earlier diagnostic should be developed.
The progress regarding sensitive, robust, fast, and cost-effective biosensors is a very active research field.
Surface-enhanced…
HUMBOLDT-UNIVERSITAET ZU BERLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Pavia
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
NANYANG TECHNOLOGICAL UNIVERSITY
Singapore, Singapore
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
